Search for: "Masters Pharmaceuticals, Inc." Results 81 - 100 of 138
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2011, 2:03 pm by Lawrence Solum
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court ruled that federal judges may no longer use the proxy of general acceptance by specialists as the test for determining the admissibility of scientific testimony. [read post]
8 Mar 2011, 7:21 am by Nabiha Syed
The Court also declined to review S&M Brands, Inc. v. [read post]
7 Mar 2011, 12:02 pm by Lyle Denniston
  The new case denied Monday was Louisiana Wholesale Drug Co., Inc., v. [read post]
7 Mar 2011, 4:30 am by Jim Dedman
Levine, the case holding that FDA approval of a pharmaceutical drug did not preempt state tort lawsuits), but Chief Justice Roberts and Justices Scalia and Alito (dissenters in the Levine case) had signaled their embrace of a broad interpretation of implied preemption, at least in highly regulated areas such as pharmaceuticals (and by extension, automobiles). [read post]
16 Nov 2010, 5:02 pm by Rebecca Shafer, J.D.
Whether you are in elementary school or working on your master's degree, your performance results in a grade being given to the work you complete. [read post]
15 Sep 2010, 7:52 am
IQPC: 8th Annual Cold Chain Distribution for Pharmaceuticals September 20-23, 2010 Philadelphia, PA Click here for more information. [read post]
1 Sep 2010, 5:05 am
IQPC: 8th Annual Cold Chain Distribution for Pharmaceuticals September 20-23, 2010 Philadelphia, PA Click here for more information. [read post]
25 Aug 2010, 7:16 am
IQPC: 8th Annual Cold Chain Distribution for Pharmaceuticals September 20-23, 2010 Philadelphia, PA Click here for more information. [read post]
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
4 Aug 2010, 6:31 am
IQPC: 8th Annual Cold Chain Distribution for Pharmaceuticals September 20-23, 2010 Philadelphia, PA Click here for more information. [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
II) – This case stems from a February 2009 challenge by the FTC and the California Attorney General concerning  Solvay Pharmaceuticals, Inc. [read post]
18 Mar 2010, 2:47 pm by Beck, et al.
  Id. at 526 (it is “not. . .proper to assume that the [plaintiff] can prove facts that it has not alleged or that the defendants [can be liable] in ways that have not been alleged”).More recently, in Dura Pharmaceuticals, Inc. v. [read post]